- The UK government announced that the breakthrough Oxford coronavirus vaccine candidate is making progress in its human trials.
- If effective and safe, 30 million doses of the ChAdOx1 nCoV-19 vaccine candidates could be ready for use in the UK by September.
- The UK, Oxford, and AstraZeneca will also mass-produce the drug for other countries once it obtains regulatory approval.
- Visit BGR’s homepage for more stories.
Several coronavirus vaccine candidates are in various phases of testing after having performed well in lab trials. Phase 1 and Phase 2 trials are running in multiple countries, including China, Germany, the UK, and the US, using multiple types of vaccine technology. Some of the vaccine candidates might be approved for emergency use as soon as this fall, including a breakthrough drug from Oxford that already works on monkeys.
If the vaccine is safe and effective on humans, as many as 30 million doses might be ready by September in Britain, of the initial 100 million capacity that AstraZeneca has promised.
Today’s Top Deals
- $50 accessory makes your home internet so much faster
- Today’s best deals: Apple Watch and AirPods Pro at all-time lows, 70¢ face masks, $18 Wi-Fi extender, $20 earbuds, more
- Don’t miss these 5 Amazon deals on kitchen gadgets and cookware
Trending Right Now:
- Stimulus check update: Here’s what happens if you missed the direct deposit deadline
- Facebook Avatars are blowing up – here’s how to create your own
- A face mask that can kill coronavirus on contact is in the works
UK may get 30M doses of a breakthrough coronavirus vaccine this fall originally appeared on BGR.com on Mon, 18 May 2020 at 15:47:12 EDT. Please see our terms for use of feeds.
Read more here:: Boy Genius Report